Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck

Florence Duffaud, P. Fumoleau, P. Chollet et al.|European Journal of Cancer|2004

Cited by 42